Healthcare only matters when it reaches people
I strive to make it
happen with you.
Healthcare only matters when it reaches people
I strive to make it
happen with you.
About Lavni
Bridging global innovation with
local healthcare realities
I'm Lavni Varyani, a life sciences and healthcare strategist, advisor, and founder of Pharma BP. I work at the intersection of policy, science and human need to help bring essential health innovation to the Middle East.
My focus is on making access possible, especially in complex or overlooked markets, by combining strategic clarity with a deep sense of care for the people.
Expertise
Driving action where it matters
Bridging the gap between people and policy by helping you navigate Middle Eastern healthcare ecosystems.
Training & capability building
Turning complexity into clarity through programmes and workshops that anchor strategy in real‑world practice. From “Discover Saudi,” HTA and negotiation strategies, to guest lectures that connect global perspective with local realities.
Speaker engagements
Facilitating dialogue that brings policy, pricing and patient perspectives together, across global stages, podcasts and panels. Always focused on conversations that are inclusive, practical and informed by real‑world experience.
Policy management
Translating ideas into frameworks that deliver meaningful, on‑the‑ground impact. Combining benchmarking, gap analysis and regional insight to shape policies that balance evidence with local nuance.
Patient‑centric work
Keeping patient needs at the centre of strategy and design. Mapping unmet needs, shaping support programmes and guiding advocacy that connects industry and regulators to real‑life challenges.
Strategic Advisory
Supporting early‑stage biotech and health tech ventures as they navigate the path from concept to market. Bringing clarity to growth, positioning and market access to help new ideas take confident steps forward.
Who I work with
Here for the changemakers
Life Sciences Executives
Expanding into new or complex markets?
I distil data, policy and practice into actionable strategy,
helping you move from insight to impact, faster.
Policy Influencers & NGOs
Working to shape equitable access?
I offer grounded, regional insight that helps turn
innovation into implementation.
Patient Groups
Fighting to be seen, heard, and served?
I amplify your voice and help ensure access isn’t
just promised, but delivered.
Key Milestones
A journey of meeting hope with action
In fragmented, fast-changing markets, I step in where clarity is needed most, helping you untangle policies, interpret pricing systems, and bring people together.
2015
Founded Pharma BP
Built a consultancy to deliver patient-focused
access across the Middle East and Africa
2023
Speaker at World Orphan
Drug Congress
Joined global peers to explore faster
access for rare and high‑need therapies
2023
Designed affordable solutions for sickle
cell disease
Developed solutions in Egypt to reduce the cost
burden for sickle cell disease patients
2024
Guest lecturer at the National
University of Singapore
Shared practical access lessons from the
Middle East and Africa with students and
professionals
2024
Founded MENAHTA
Launched the region’s first HTA forum for
shared learning and local policy collaboration
2024
Enabled access for two ATMP launches
Partnered on two of MENA’s first Advanced Therapy
Medicinal Products (ATMP) approvals, bringing
advanced therapies closer to patients
2024
Built support programmes in
dermatology care
Defined pharmaceutical support programmes
for patients with dermatological conditions
2025
Advised on breakthrough
application for an oncology drug
Supported a major oncology
manufacturer in submitting a dossier for
breakthrough designation status
2025
Contributed to diabetes access policy
Worked on access-focused policy in Saudi Arabia
supporting the entry of a novel diabetes therapy
2015
Founded Pharma BP
Built a consultancy to deliver patient-focused
access across the Middle East and Africa
2023
Speaker at World Orphan
Drug Congress
Joined global peers to explore faster
access for rare and high‑need therapies
2023
Designed affordable solutions for sickle
cell disease
Developed solutions in Egypt to reduce the cost
burden for sickle cell disease patients
2024
Guest lecturer at the National
University of Singapore
Shared practical access lessons from the
Middle East and Africa with students and
professionals
2024
Founded MENAHTA
Launched the region’s first HTA forum for
shared learning and local policy collaboration
2024
Enabled access for two ATMP launches
Partnered on two of MENA’s first Advanced Therapy
Medicinal Products (ATMP) approvals, bringing
advanced therapies closer to patients
2024
Built support programmes in
dermatology care
Defined pharmaceutical support programmes
for patients with dermatological conditions
2025
Advised on breakthrough
application for an oncology drug
Supported a major oncology
manufacturer in submitting a dossier for
breakthrough designation status
2025
Contributed to diabetes access policy
Worked on access-focused policy in Saudi Arabia
supporting the entry of a novel diabetes therapy
Case Studies
Together, we make a difference
These case studies show how purposeful collaborations create an impact.
It's about people, at the heart of policy
Presence
Being the voice of reason & reach
Join me as I reflect, build and share
Follow on:
Peer Testimonials
Testimonies to a shared vision
Reflections from shared journeys to better care.
I was introduced to Lavni by a mutual connection and was immediately blown away by her profile and experience. She was introduced to me as being the expert on all things market access, especially in the GCC region. I have worked closely with Lavni on a number of projects in the GCC and her expertise and partnership have been immensely valuable. I can now personally confirm that she is indeed the market access expert in the GCC and have loved working with her over the past 2 years.
Louise L.
Senior Director, Global Value, Access & Pricing, Rare Disease Biotech
It has been a pleasure partnering with Lavni Varyani on projects focused on market access. She brings a rare combination of deep expertise in GCC market access and policy, along with a genuine commitment to patient-centric solutions. Lavni is proactive, agile, and transparent, making her a trusted partner on complex market access and HEOR projects. Her insights help drive meaningful deliverables on projects and help in-house functions to assess the impact on business and identify access opportunities. I greatly value our partnership and look forward to future collaborations.
Martyna Giedrojc-Amir
Director Value & Access, Diagnostics Manufacturer
Lavni is our trusted partner for all access work in GCC. Over 5 years, I have taken advantage of Lavni's expertise and advice across the whole of GCC multiple times. Her advice has allowed me to perfect the go-to market access strategy for small molecules and CGTs, as well as assess the impact of certain access risks and monitor the evolution of the KSA access framework.
Andrea F.
Director, International Pricing & Market Access, Rare Disease Biotech
I was introduced to Lavni by a mutual connection and was immediately blown away by her profile and experience. She was introduced to me as being the expert on all things market access, especially in the GCC region. I have worked closely with Lavni on a number of projects in the GCC and her expertise and partnership have been immensely valuable. I can now personally confirm that she is indeed the market access expert in the GCC and have loved working with her over the past 2 years.
Louise L.
Senior Director, Global Value, Access & Pricing, Rare Disease Biotech
It has been a pleasure partnering with Lavni Varyani on projects focused on market access. She brings a rare combination of deep expertise in GCC market access and policy, along with a genuine commitment to patient-centric solutions. Lavni is proactive, agile, and transparent, making her a trusted partner on complex market access and HEOR projects. Her insights help drive meaningful deliverables on projects and help in-house functions to assess the impact on business and identify access opportunities. I greatly value our partnership and look forward to future collaborations.
Martyna Giedrojc-Amir
Director Value & Access, Diagnostics Manufacturer
Lavni is our trusted partner for all access work in GCC. Over 5 years, I have taken advantage of Lavni's expertise and advice across the whole of GCC multiple times. Her advice has allowed me to perfect the go-to market access strategy for small molecules and CGTs, as well as assess the impact of certain access risks and monitor the evolution of the KSA access framework.
Andrea F.
Director, International Pricing & Market Access, Rare Disease Biotech
Let's Collaborate
Let's make healthcare for all, a reality
Looking to bring your innovation into the Middle East? Partner with a guide who knows the tact and terrain. Reach out now.
